urolift system for treatment bph and enlarged prostate
DESCRIPTION
Innovations in Treatment of BPH and Enlarged Prostate: The emerging role of the new transprostatic implant using the Urolift System for treatment of BPH symptoms caused by enlarged prostate. Discussion of the clinical trial results, treatment options for #BPH and where does #Urolift procedure fit in the modern treatment for enlarged #prostate.TRANSCRIPT
Urolift System for Treatment of BPH / Enlarged ProstateInnovations in Treatment of Enlarged Prostate
Alex Shteynshlyuger MD
Board Certified UrologistDirector of Urology
New York Urology Specialists2014
www.NewYorkUrologySpecialists.com
Why Urolift for BPH?
New York Urology Specialists is the first practice in New York City, and one of the first practices in the United States, to offer Urolift as a treatment option for BPH for our patients.
Why all the Excitement about the Urolift System?
The goal of this presentation is to provide an overview of the treatment options for BPH and to explain where Urolift fits among other treatment options.
www.NewYorkUrologySpecialists.com
What is BPH or Enlarged Prostate? Who Gets it?
BPH refers to benign prostatic hypertrophy, a medical term for enlarged prostate.
What causes prostate to grow?Over time, under hormonal influence (from testosterone) the
prostate increases in size. Prostate gland has volume of 15-20 ml or grams in young men (20-30 years old). By the time men reach age 50, it is not uncommon for the prostate gland to grow to 40-50 grams.
www.NewYorkUrologySpecialists.com
Who Gets Enlarged Prostate?
Prostate grows throughout a man’s life.
Symptoms of prostate growth usually occurs in men who are over 40-45 years old.
It is fairly uncommon for men younger than 40 to experience symptoms of enlarged prostate.
The symptoms are most common after age 50; as men age they are more likely to develop symptoms of enlarged prostate over time.
www.NewYorkUrologySpecialists.com
Symptoms of Enlarged Prostate / BPH
Not all men with enlarged prostate develop symptoms of BPH. Some men with very large prostate may have minimal or no symptoms.
Common symptoms of BPH:- Frequent urination- Feeling of incomplete bladder emptying- Need to urinate at night- Slow urine stream- Urgency to urinate; inability to hold urine - Blood in urine / Blood in semen
www.NewYorkUrologySpecialists.com
Why do some men have a very large prostate but no symptoms?
Prostate can grown inward on the urethra or outward into the pelvis.
If the prostate grows outward, it may become very large but cause no noticeable symptoms.
If the prostate grows inward and pushes on urethra it may block the urethra and cause symptoms without being very large.
Small change in the diameter of the urethra can have a tremendous effect on the flow of urine.
www.NewYorkUrologySpecialists.com
Warning about Self-Treatment
The symptoms of Enlarged Prostate / BPH are similar to the symptoms caused by prostate cancer and bladder cancer.
The men at risk for BPH are the same men who are at risk for prostate cancer (age >50).
It is important to have a thorough urological evaluation including tumor markers (PSA, PHI, etc) for men at risk.
www.NewYorkUrologySpecialists.com
Treatment Options for Symptoms of Enlarged Prostate
Medical Treatment: Sexual Side effects related mostly to ejaculation- Alpha blockers (Flomax, Rapaflo, etc)
- Side Effects: retrograde ejaculation – reversible if medications are stopped
- Combination of alpha blockers and alpha-reductase inhibitors (Proscar - Finasteride, dutasteride)
- Side Effects: retrograde ejaculation; <5% risk of ED; lack of ejaculation
- PDE5 inhibitors (Cialis, Viagra, etc) – true benefit uncertain as there is no effect on urinary flow
- Side effects: many but few are dangerous; benefit of improved erections
www.NewYorkUrologySpecialists.com
Treatment Options for Symptoms of Enlarged Prostate
Minimally Invasive In-Office Treatment OptionsMicrowave – effective for mild to moderate symptoms; minimal
sexual side effects; low rate of retrograde ejaculation; 30% need retreatment within 5 years
TUNA – effective for mild to moderate symptoms; minimal sexual side effects; very low rate of retrograde ejaculation; 25% need retreatment within 3-5 years
Urolift System for BPH – effective for mild to severe symptoms; no sexual side effects reported in studies; no retrograde ejaculation; <10% retreatment rate at 2 years.
www.NewYorkUrologySpecialists.com
Treatment Options for Symptoms of Enlarged Prostate
Minimally Invasive Surgical Options: All have similar benefits and risks; require anesthesia; all lead to some sexual side effects.
- Lasers (Greenlight, Holmium, etc)- TURP (Monopolar, Bipolar, etc)- Enucleation
Open Prostatectomy- Rarely performed nowadays- Only performed for very large prostate- Sexual side effects and risks of surgery
www.NewYorkUrologySpecialists.com
Urolift Transprostatic Implant System
Benefits of Transprostatic Implant using the Urolift System
Logically anatomic solution to obstruction. Retracts the obstructing prostate tissue. Equivalent to
angioplasty with a stent for blockage of the heart vessels. Rapid relief of symptoms within days of treatment. No need for daily medication use – alternative to
medications No risk of Erectile Dysfunction – vs current treatment
options No risk of Ejaculatory Dysfunction – vs current treatment
options
www.NewYorkUrologySpecialists.com
L.I.F.T Randomized Controlled StudyJ Urol. 2013 Dec;190(6):2161-7. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. http://www.ncbi.nlm.nih.gov/pubmed/23764081
206 patients randomized to placebo or Urolift- All procedures done under local anesthesia (no IV sedation)- 4.9 implants on average per patient
Baseline patient characteristics: Average age = 67 mean prostate volume = 45 ml (moderately large prostate; average for
age) AUA SS = 22.2 (severe urinary symptoms) Qmax = 8.9 (fairly poor urinary flow) PSA=2.9 IIEF=13 (moderate to severe erectile dysfunction) QOL = 4.6
www.NewYorkUrologySpecialists.com
L.I.F.T Randomized Controlled StudyJ Urol. 2013 Dec;190(6):2161-7. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. http://www.ncbi.nlm.nih.gov/pubmed/23764081
Results Summary: Can be done in the office under local anesthesia Durability: good long-term effectiveness at 1 and 2 years 8-12 point drop in IPPS within weeks; minimal to no risk of hospital admission or
readmission Does not preclude future treatment with any of the other treatment options (Lasers,
TURP, etc)
Better than placebo: IPPS, Qmax, QOL, BPHII Qmax improvement by 50% - improved urinary flow AUA SS improvement by 50% (11 points) – improved urinary symptoms
(frequent urination, incomplete bladder emptying, urgency, urination at night and quality of life)
Benefit unchanged after 2 years No erectile dysfunction No ejaculatory dysfunction
www.NewYorkUrologySpecialists.com
L.I.F.T Randomized Controlled StudyJ Urol. 2013 Dec;190(6):2161-7. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. http://www.ncbi.nlm.nih.gov/pubmed/23764081
Urolift – Results from Randomized Controlled Study shows benefit in every parameter measured: urinary function, sexual function and post-void residual. Results at 3 months are unchanged at 1 year.
www.NewYorkUrologySpecialists.com
Outcome Measure
PUL-ITT Group Mean, SD (No. responses) - UroliftControl ITT Group Mean, SD (No. responses) - Placebo
p Value (2-sample t - test)Baseline 3 Mos Change Baseline 3 Mos Change
AUASI 22.2, 5.48 (140) 11.2, 7.65 (140) −11.1, 7.67 (140) 24.4, 5.75 (66) 18.5, 8.59 (66) −5.9, 7.66 (66) 0.003
Qmax (ml/sec) 8.02, 2.43 (126) 12.29, 5.40 (126) 4.28, 5.16 (126) 7.93, 2.41 (56) 9.91, 4.29 (56) 1.98, 4.88 (56) 0.005
QOL 4.6, 1.1 (140) 2.4, 1.7 (140) −2.2, 1.8 (140) 4.7, 1.1 (66) 3.6, 1.6 (66) −1.0, 1.5 (66) <0.001
BPHII 6.9, 2.8 (140) 3.0, 3.1 (140) −3.9, 3.2 (140) 7.0, 3.0 (66) 4.9, 3.2 (66) −2.1, 3.3 (66) <0.001
MSHQ-EjD 8.7, 3.1 (94) 10.9, 3.2 (94) 2.2, 2.5 (94) 8.8, 3.1 (50) 10.5, 3.5 (50) 1.7, 2.6 (50) 0.283
MSHQ-Bother 2.4, 1.7 (117) 1.6, 1.7 (117) −0.8, 1.5 (117) 2.2, 1.7 (60) 1.5, 1.7 (60) −0.7, 1.6 (60) 0.595
IIEF-5 13.3, 8.4 (132) 13.4, 9.2 (132) 0.1, 5.8 (132) 13.7, 8.5 (65) 15.2, 8.5 (65) 1.5, 6.4 (65) 0.139
PVR (ml) 85.5, 69.2 (140) 75.8, 83.9 (140) −9.7, 85.5 (140) 85.6, 70.8 (65) 63.4, 64.0 (65) −22.2, 70.7 (65) 0.306
L.I.F.T Randomized Controlled Study
www.NewYorkUrologySpecialists.com
Who is a Good Candidate for Urolift Procedure?
Any age Any comorbidities – can do it fairly safely on aspirin;
patients with cardiac, pulmonary disease can have the procedure under local anesthesia just like everyone else.
Should NOT have a UTI – pretreat UTI if present Predominantly lateral prostatic lobe obstruction Minimal or no median prostate lobe obstruction Minimal or moderate PVR (<250 ml)
- But can treat men with high PVR and implant more implants if necessary
- Treatment failure does not preclude other treatments
www.NewYorkUrologySpecialists.com
The Role of Urolift in Treatment of Men with BPH.
At New York Urology Specialists we have a very diverse patient populationSexual Side Effects of BPH Treatment Are ImportantMany men who are young with symptoms of enlarged prostateMany men who are older with symptoms of enlarged prostate are very sexually active Many men who for health reasons are too frail to undergo surgical procedures
www.NewYorkUrologySpecialists.com
The Role of Urolift in Treatment of Men with BPH.
Men with Mild to Moderate Urinary Symptoms-Medical Treatment is still the mainstay of treatment for BPH-Alpha blockers are both diagnostic and therapeutic-If moderate or good response to alpha-blockers, Urolift is an option for men who would prefer to avoid daily medications-Men who progress on medical therapy for BPH (symptoms worsen on flomax/uraxatral, proscar/avadart):
- If quality for Urolift (cystoscopic examination, PVR), Urolift is a good option for many men
www.NewYorkUrologySpecialists.com
Urolift and Urinary Retention
Men with transient urinary retention after a precipitating event:-Often a sign of underlying BPH/prostatic enlargement-Would probably benefit from treatment even if not very symptomatic; uroflow / PVR and urodynamics should be considered-Urolift may be an option in leu of medical treatment
www.NewYorkUrologySpecialists.com
Who Should NOT Have Urolift
Men with complications that result from BPH that are life-threatening:-Renal insufficiency-Recurrent UTI/Sepsis
Definitive treatment with Lasers or TURP should be promptly offered to patients. Urolift is not a good option for these men.
Prostatic Bleeding-Urolift does not address the problem that occurs in men with prostatic bleeding which is hypervascularity and obstruction; very friable tissue
Definitive treatment with Lasers or TURP should be promptly offered to patients. Urolift is not a good option for these men.
www.NewYorkUrologySpecialists.com
Who Should NOT Have Urolift
Suspect Other Abnormalities:Risk factors for prostate cancer: abnormal DRE / elevated PSA, PHI or 4KScoreEvaluate patients for prostate cancer: prostate biopsy prior to urolift
www.NewYorkUrologySpecialists.com
Questions about BPH Treatment or Urolift?
Alex Shteynshlyuger [email protected]
www.NewYorkUrologySpecialists.com